JG
FENC icon

Jefferies Group’s Fennec Pharmaceuticals FENC Stock Holding History

Jefferies Group’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$81K Buy
+10,000
New +$68.6K ﹤0.01% 1483

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Jefferies Group's FENC Position: Q3 2022 in Review

Jefferies Group opened a new position in Fennec Pharmaceuticals (FENC) in Q3 2022: 34,539 shares worth $280K. The stake represents ﹤0.01% of the portfolio and ranks #1254 among its holdings.

31 funds tracked by Wall St. Rank hold FENC as of Q3 2022.

  • Jefferies Group held 34,539 shares of Fennec Pharmaceuticals worth $280K as of Q3 2022.
  • Fennec Pharmaceuticals was a new Jefferies Group position in Q3 2022.
  • Fennec Pharmaceuticals made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1254 holding.
  • 31 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.